Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 2012 | Published + Supplemental Material
Journal Article Open

Regulation of Monocyte Functional Heterogeneity by miR-146a and Relb

Abstract

Monocytes serve as a central defense system against infection and injury but can also promote pathological inflammatory responses. Considering the evidence that monocytes exist in at least two subsets committed to divergent functions, we investigated whether distinct factors regulate the balance between monocyte subset responses in vivo. We identified a microRNA (miRNA), miR-146a, which is differentially regulated both in mouse (Ly-6C^(hi)/Ly-6C^(lo)) and human (CD14^(hi)/CD14^(lo)CD16^+) monocyte subsets. The single miRNA controlled the amplitude of the Ly-6C^(hi) monocyte response during inflammatory challenge whereas it did not affect Ly-6C^(lo) cells. miR-146a-mediated regulation was cell-intrinsic and depended on Relb, a member of the noncanonical NF-κB/Rel family, which we identified as a direct miR-146a target. These observations not only provide mechanistic insights into the molecular events that regulate responses mediated by committed monocyte precursor populations but also identify targets for manipulating Ly-6C^(hi) monocyte responses while sparing Ly-6C^(lo) monocyte activity.

Additional Information

© 2012 The Authors. Received: October 12, 2011. Revised: February 14, 2012. Accepted: February 24, 2012. Published online: April 5, 2012. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/ legalcode). The authors thank Mike Waring, Andrew Cosgrove, and Adam Chicoine (Ragon Institute of MGH, MIT, and Harvard) for cell sorting; Borja Saez (Harvard Medical School), Patrick Stern, and David Feldser (MIT) for help with retroviral gene transfer. Charles Vanderburg and Anna Krichevsky (Harvard Medical School) for help with analytical RNA techniques; and Yoshiko Iwamoto and Joshua Dunham (MGH Center for Systems Biology) for help with immunofluorescence staining and imaging. M.E. is part of the International PhD program ''Cancer and Immunology'' at the University of Lausanne, Switzerland and was supported by the American Association for Cancer Research Centennial Predoctoral Fellowship and the Boehringer Ingelheim Fonds. This work was supported in part by National Institutes of Health grants NIH-R01 AI084880 (to M.J.P.) and P30 DK043351 (to M.J.P. and R.X.). D.B. is a director and chairman of the scientific advisory board of Regulus Therapeutics, a biotech company developing miRNA-based drugs.

Attached Files

Published - 1-s2.0-S2211124712000666-main.pdf

Supplemental Material - PIIS2211124712000666.mmc1.pdf

Files

PIIS2211124712000666.mmc1.pdf
Files (4.1 MB)
Name Size Download all
md5:3b8f0dd2d1d9d9ce655bb0408ccfec39
2.7 MB Preview Download
md5:ed482a4f3f6a083444825b9ec26fb637
1.4 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023